Prof. Dr. Johannes von Kempis
Rheumatologie · Dept. I
Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase
Schiff M, von Kempis J, Goldblum R, Tesser J, Müller R. Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase. Ann Rheum Dis 2014; 73:2174-7.
Jun 27, 2014Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase
Jun 27, 2014Ann Rheum Dis 2014; 73:2174-7
Schiff Michael H, von Kempis Johannes, Goldblum Ronald, Tesser John R, Müller Rüdiger
Biological agents in monotherapy for the treatment of rheumatoid arthritis
Gabay C, Hasler P, Kyburz D, So A, Villiger P, von Kempis J, Walker U. Biological agents in monotherapy for the treatment of rheumatoid arthritis. Swiss Med Wkly 2014; 144:w13950.
Apr 10, 2014Biological agents in monotherapy for the treatment of rheumatoid arthritis
Apr 10, 2014Swiss Med Wkly 2014; 144:w13950
Gabay C, Hasler P, Kyburz D, So A, Villiger P, von Kempis Johannes, Walker U
Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort
Müller R, Kaegi T, Finckh A, Haile S, Schulze-Koops H, von Kempis J, on behalf of the SCQM physicians. Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort. Rheumatology (Oxford) 2013
Dec 17, 2013Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort
Dec 17, 2013Rheumatology (Oxford) 2013
Müller Rüdiger, Kaegi Toni, Finckh Axel, Haile Sarah, Schulze-Koops Hendrik, von Kempis Johannes, on behalf of the SCQM physicians
Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination
Müller R, Maier R, Hoschler K, Zambon M, Ludewig B, Herrmann M, Schulze-Koops H, von Kempis J. Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination. Clin Exp Rheumatol 2013; 31:723-30.
Jun 14, 2013Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination
Jun 14, 2013Clin Exp Rheumatol 2013; 31:723-30
Müller Rüdiger, Maier Reinhard, Hoschler Katja, Zambon Maria, Ludewig Burkhard, Herrmann Martin, Schulze-Koops Hendrik, von Kempis Johannes
Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective
Zeidler J, Mittendorf T, Müller R, von Kempis J. Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective. Health Econ Rev 2012; 2:20.
Sep 28, 2012Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective
Sep 28, 2012Health Econ Rev 2012; 2:20
Zeidler Jan, Mittendorf Thomas, Müller Rüdiger, von Kempis Johannes
Detection of low level cryoglobulins by flow cytometry
Müller R, Schett G, von Kempis J, Sheriff A, Maihöfner C, Kern P, Franz S, Munoz L, Winkler S, Vogt B, Herrmann M. Detection of low level cryoglobulins by flow cytometry. Cytometry A 2012; 81:883-7.
Sep 7, 2012Detection of low level cryoglobulins by flow cytometry
Sep 7, 2012Cytometry A 2012; 81:883-7
Müller Rüdiger, Schett Georg, von Kempis Johannes, Sheriff Ahmed, Maihöfner Christian, Kern Peter, Franz Sandra, Munoz Luis E, Winkler Silke, Vogt Birgit, Herrmann Martin
Use of abatacept in rheumatoid arthritis
von Kempis J, Dudler J, Hasler P, Kyburz D, Tyndall A, Zufferey P, Villiger P. Use of abatacept in rheumatoid arthritis. Swiss Med Wkly 2012; 142:w13581.
May 11, 2012Use of abatacept in rheumatoid arthritis
May 11, 2012Swiss Med Wkly 2012; 142:w13581
von Kempis Johannes, Dudler Jean, Hasler Paul, Kyburz Diego, Tyndall Alan, Zufferey Pascal, Villiger Peter M
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion
Walker U, Courvoisier D, Dudler J, Aeberli D, von Kempis J, Scherer A, Finckh A, Swiss Clinical Quality Management Programme in Rheumatic Diseases. Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion. Rheumatology (Oxford) 2010; 50:243-4.
Aug 17, 2010Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion
Aug 17, 2010Rheumatology (Oxford) 2010; 50:243-4
Walker Ulrich A, Courvoisier Delphine S, Dudler Jean, Aeberli Daniel, von Kempis Johannes, Scherer Almut, Finckh Axel, Swiss Clinical Quality Management Programme in Rheumatic Diseases
Clinical Trials in Rheumatology
Müller R, von Kempis J. Clinical Trials in Rheumatology. Heidelberg: Springer, 2010. ISBN 978-1-84996-383-1.
Jan 1, 2010Clinical Trials in Rheumatology
Jan 1, 2010Springer, ISBN 978-1-84996-383-1
Müller Rüdiger, von Kempis Johannes
Rheuma-Drugfinder 2010
Müller R, von Kempis J. Rheuma-Drugfinder 2010. 2010
Jan 1, 2010Rheuma-Drugfinder 2010
Jan 1, 20102010
Müller Rüdiger, von Kempis Johannes
Abdominal pain in a patient with ankylosing spondylitis under treatment with infliximab
Cooper J, Flückiger B, Traichl B, Diener P, Otto P, von Kempis J. Abdominal pain in a patient with ankylosing spondylitis under treatment with infliximab. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2009; 15:244-6.
Aug 1, 2009Abdominal pain in a patient with ankylosing spondylitis under treatment with infliximab
Aug 1, 2009Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2009; 15:244-6
Cooper Julian, Flückiger Beat, Traichl Birgit, Diener Pierre-André, Otto Petra, von Kempis Johannes
Soluble CD21 in sera and synovial fluid of arthritic patients
Grottenthaler T, von Kempis J, Goldacker S, Illges H. Soluble CD21 in sera and synovial fluid of arthritic patients. Rheumatology international 2006; 26:240-3.
Jan 1, 2006Soluble CD21 in sera and synovial fluid of arthritic patients
Jan 1, 2006Rheumatology international 2006; 26:240-3
Grottenthaler Thomas, von Kempis Johannes, Goldacker Sigune, Illges Harald
Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature
Beuthien W, Mellinghoff H, von Kempis J. Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature. Clinical rheumatology 2005; 24:507-15.
Sep 1, 2005Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature
Sep 1, 2005Clinical rheumatology 2005; 24:507-15
Beuthien Wilke, Mellinghoff H, von Kempis Johannes
Popliteal artery entrapment with peripheral thromboembolism
Beuthien W, De Potzolli O, Mellinghoff H, von Kempis J. Popliteal artery entrapment with peripheral thromboembolism. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2004; 10:147-9.
Jun 1, 2004Popliteal artery entrapment with peripheral thromboembolism
Jun 1, 2004Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2004; 10:147-9
Beuthien Wilke, De Potzolli Oliver, Mellinghoff Hans-Ulrich, von Kempis Johannes
Skin reaction to adalimumab
Beuthien W, Mellinghoff H, von Kempis J. Skin reaction to adalimumab. Arthritis and rheumatism 2004; 50:1690-2.
May 1, 2004Skin reaction to adalimumab
May 1, 2004Arthritis and rheumatism 2004; 50:1690-2
Beuthien W, Mellinghoff H, von Kempis Johannes
Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis
Masilamani M, von Kempis J, Illges H. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis. Rheumatology (Oxford, England) 2004; 43:186-90.
Feb 1, 2004Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis
Feb 1, 2004Rheumatology (Oxford, England) 2004; 43:186-90
Masilamani M, von Kempis Johannes, Illges H
Sarkoidose und Sacriliitis: Erstmanifestation oder Koinzidenz der Sarkoidose mit einer Spondylarthropathie?
Mellinghoff H, Anrig M, Beuthen W, von Kempis J. Sarkoidose und Sacriliitis: Erstmanifestation oder Koinzidenz der Sarkoidose mit einer Spondylarthropathie?. Swiss Med Forum 2004; 4:173-174.
Jan 1, 2004Sarkoidose und Sacriliitis: Erstmanifestation oder Koinzidenz der Sarkoidose mit einer Spondylarthropathie?
Jan 1, 2004Swiss Med Forum 2004; 4:173-174
Mellinghoff H, Anrig M, Beuthen W, von Kempis Johannes
The combination of different antiphospholipid antibody subgroups in the sera of patients with autoimmune diseases is a strong predictor for thrombosis. A retrospective study from a single center
von Landenberg P, Schölmerich J, von Kempis J, Lackner K. The combination of different antiphospholipid antibody subgroups in the sera of patients with autoimmune diseases is a strong predictor for thrombosis. A retrospective study from a single center. Immunobiology 2003; 207:65-71.
Jan 1, 2003The combination of different antiphospholipid antibody subgroups in the sera of patients with autoimmune diseases is a strong predictor for thrombosis. A retrospective study from a single center
Jan 1, 2003Immunobiology 2003; 207:65-71
von Landenberg Philipp, Schölmerich Jürgen, von Kempis Johannes, Lackner Karl J
Arthropathy in hereditary hemochromatosis
von Kempis J. Arthropathy in hereditary hemochromatosis. Current opinion in rheumatology 2001; 13:80-3.
Jan 1, 2001Arthropathy in hereditary hemochromatosis
Jan 1, 2001Current opinion in rheumatology 2001; 13:80-3
von Kempis Johannes
[The North American Spine Society Lumbar Spine Outcome Assessment Instrument: translation and psychometric analysis of the German version in rehabilitation patients with chronic back pain]
Schochat T, Rehberg W, von Kempis J, Stucki G, Jäckel W. [The North American Spine Society Lumbar Spine Outcome Assessment Instrument: translation and psychometric analysis of the German version in rehabilitation patients with chronic back pain]. Zeitschrift für Rheumatologie 2000; 59:303-13.
Oct 1, 2000[The North American Spine Society Lumbar Spine Outcome Assessment Instrument: translation and psychometric analysis of the German version in rehabilitation patients with chronic back pain]
Oct 1, 2000Zeitschrift für Rheumatologie 2000; 59:303-13
Schochat T, Rehberg W, von Kempis Johannes, Stucki G, Jäckel W H